Glucocorticoid Receptor Confers Resistance to Anti-Androgens by Bypassing Androgen Receptor Blockade

The treatment of advanced prostate cancer has been transformed by novel antiandrogen therapies such as enzalutamide. Here we identify induction of glucocorticoid receptor (GR) expression as a common feature of drug resistant tumors in a credentialed preclinical model, a finding also confirmed in pat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Arora, Vivek K., Schenkein, Emily, Murali, Rajmohan, Subudhi, Sumit K., Wongvipat, John, Balbas, Minna D., Shah, Neel, Cai, Ling, Efstathiou, Eleni, Logothetis, Chris, Zheng, Deyou, Sawyers, Charles L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3932525/
https://ncbi.nlm.nih.gov/pubmed/24315100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cell.2013.11.012
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak